The CDC estimates that up to 86% of new COVID-19 cases stem from the latest mutation. The virus continues to evolve so rapidly that "our immune systems have not been able to keep up," an expert says.
Flu is rising, and COVID levels are higher than last season's peak. But COVID hospitalizations and deaths are down. Nonetheless, COVID is still the most dangerous virus circulating.
As a deadline to allocate federal COVID-19 cash approaches next year, states must decide how much to invest in maintaining warehouses and supply stockpiles after panic buying during the pandemic.
This was the year a lot people finally exhaled. The pandemic was declared no longer an emergency. But viral threats are still with us and there are lessons we still haven't learned.
Dozens of makeshift centers were built and now stand empty. Now authorities want to revive a stagnating economy and attract young workers to cities by turning the structures into affordable housing.
Starting in early December, about 19,000 school districts will have the chance to order free rapid COVID tests from the federal stockpile for their students, staff and others in the community.
As the country enters its fourth holiday season with COVID-19, experts offer advice about how Americans should navigate the risks and what precautions still make sense.
Over the weekend, Central Georgia’s largest hospital said goodbye to a flock of shipping containers used to treat overflow patients during the height of the COVID-19 pandemic.
The federal government has invested hundreds of millions of dollars to boost American production of medical gloves, but some companies say it's not enough when imported gloves have gotten cheaper.
The study published this month in the journal Cell suggests treating long COVID with antidepressants such as Prozac and other medications classified as selective serotonin reuptake inhibitors (SSRI) may help people recover faster.
Scientists studying the causes of long COVID symptoms are proposing a surprising pathway. Their research weaves together several prominent lines of evidence on what might be driving the condition.
National data shows COVID-19 levels are moderate. In most of the U.S., levels of other respiratory viruses are low, although RSV is ticking up in some southeastern states.
When COVID-19 first emerged, Linsey Marr suspected right away it spread through the air. Time has proved this aerosols engineer right. Now she's being honored with a MacArthur "genius grant."
